GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Genes Tech Group Holdings Co Ltd (HKSE:08257) » Definitions » Cash Conversion Cycle

Genes Tech Group Holdings Co (HKSE:08257) Cash Conversion Cycle : 586.42 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Genes Tech Group Holdings Co Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Genes Tech Group Holdings Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 73.11.
Genes Tech Group Holdings Co's Days Inventory for the three months ended in Dec. 2023 was 574.59.
Genes Tech Group Holdings Co's Days Payable for the three months ended in Dec. 2023 was 61.28.
Therefore, Genes Tech Group Holdings Co's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 586.42.


Genes Tech Group Holdings Co Cash Conversion Cycle Historical Data

The historical data trend for Genes Tech Group Holdings Co's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genes Tech Group Holdings Co Cash Conversion Cycle Chart

Genes Tech Group Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 345.49 463.66 455.25 353.51 417.57

Genes Tech Group Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.61 493.76 338.26 373.31 586.42

Competitive Comparison of Genes Tech Group Holdings Co's Cash Conversion Cycle

For the Semiconductor Equipment & Materials subindustry, Genes Tech Group Holdings Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genes Tech Group Holdings Co's Cash Conversion Cycle Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, Genes Tech Group Holdings Co's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Genes Tech Group Holdings Co's Cash Conversion Cycle falls into.



Genes Tech Group Holdings Co Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Genes Tech Group Holdings Co's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=55.16+428.54-66.13
=417.57

Genes Tech Group Holdings Co's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=73.11+574.59-61.28
=586.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genes Tech Group Holdings Co  (HKSE:08257) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Genes Tech Group Holdings Co Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Genes Tech Group Holdings Co's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Genes Tech Group Holdings Co (HKSE:08257) Business Description

Traded in Other Exchanges
N/A
Address
No. 80, Baotai 3rd Road, Hsinchu County, Zhubei City, TWN, 30244
Genes Tech Group Holdings Co Ltd is engaged in the business of Provision of turnkey solution and Trading of used semiconductor manufacturing equipment and parts. It generates prime revenue from the Provision of turnkey solution segment. The company offers turnkey solution of used SME and Parts to customers who need to alter and upgrade the semiconductors of production systems from time to time. The SME and parts supplied by the group include furnaces, clean tracks, and other related items, which are used at the front-end of the semiconductor manufacturing process, wafer fabrication, such as deposition, photoresist coating, and development. It has a business presence in Taiwan, the PRC, Singapore, the United States, Japan and other countries.

Genes Tech Group Holdings Co (HKSE:08257) Headlines

No Headlines